The impairment of plasma kallikrein action on homeostasis by kallikrein inhibitor comprising RGD sequence established a novel target in antithrombotic therapies by Medina, A.F., Salu, B.R., de Brito, M.V., Bonturi, C.R., Meneghetti, M.C.Z., Maffei, F.H.A., Oliva, M.L.V.

Get full text